Stephen P. Squinto

This profile gathers the share dealings of Stephen P. Squinto across 2 companies, led by Alexion Pharmaceuticals Inc and SpringWorks Therapeutics, Inc. In total, 199 filings cover trades dated from 9 January 2006 to 19 May 2022.

Both buying and selling appear: 1 purchase worth €4.5M, against 118 sales worth €61.6M. Taken together, the sales exceed the purchases by €57.2M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 13 share grants and 61 option exercises.

The record was last updated on 20 May 2022 with a share grant in SpringWorks Therapeutics, Inc. The clock since the last published purchase (19 September 2019) now reads 2,607 days. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.